Yongping Guo
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pathological perspective reveals a novel hemodialyzer reaction: a case report.
Journal: BMC nephrology
Published: January 11, 2025
Risk Factors and Drug Efficacy for Severe Illness in Hemodialysis Patients Infected with the Omicron Variant of COVID-19.
Journal: Kidney & blood pressure research
Published: May 29, 2023
MiRNA-200b level in peripheral blood predicts renal interstitial injury in patients with diabetic nephropathy.
Journal: Journal of medical biochemistry
Published: June 22, 2022
LncRNA TCF7 contributes to high glucose-induced damage in human podocytes by up-regulating SEMA3A via sponging miR-16-5p.
Journal: Journal of diabetes investigation
Published: June 08, 2022
Efficacy and safety of Bailing capsules in the treatment of type 2 diabetic nephropathy: a meta-analysis.
Journal: Annals of palliative medicine
Published: August 17, 2020
Notoginsenoside R1 ameliorates podocyte adhesion under diabetic condition through α3β1 integrin upregulation in vitro and in vivo.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: September 22, 2014
Preventive Effects of a Natural Anti-Inflammatory Agent, Astragaloside IV, on Ischemic Acute Kidney Injury in Rats.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: March 08, 2013
Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.
Journal: Apoptosis : an international journal on programmed cell death
Published: January 18, 2013
Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
Journal: Cytokine
Published: August 16, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026